Obviously the EPS release for GTHP is not very relevant. The company will continue to bleed cash for a couple more quarters. More importantly, GTHP has the approval to start selling their devices in Europe and outside the US. I expect the company to be operating above break even late 2013. FDA approval will come the question is when. Most participants were expecting approval last year. if we get approval this year the stock moves closer to $3 pretty quick. The value of the company with FDA approval is @$10 in my opinion. GHTP has hired personnel to aid the approval process. Will it later happen this year? Not sure but I am fairly optimist that approval will occur in the next 12-15 months. Patience. Dead money until we hear from the FDA.
It is not due until next week. Relax. Either way GTHP works. The have now the business outside the US to start production in a significant way. Approval would be great but if it does not happen you can grow the business elsewhere while you wait for the FDA. FDA approval jump starts the process and the timing of success. Either way the company is a winner IMHO the question is the timing.